MSc Precision Medicine Cancer Omics
This MSc gives pharmacy, biochemistry, biomedical and biology graduates the opportunity to help shape the future of healthcare, through the study of precision medicine and oncology.
Precision medicine personalises disease prevention and treatment, considering the differences in people’s genes, environments, and lifestyles to target the right treatments, to the right patients, at the right time.
Alongside this, you’ll determine advances in omics strategies, to identify and profile cancer tumours, including DNA profiling and sequencing, mRNA patterns, protein and phosphorylated protein expression, and lipid alternations in oncology. You’ll learn approaches to identify novel therapeutic targets and predictive biomarkers to recognise patients that are likely to benefit from specific treatment.
This highly specialised course has a large clinical component and includes an optional placement at Brighton and Sussex University Hospital, or in Brighton and Sussex Medical School (BSMS) or campus-based omics labs.
Our established links with NHS trusts and BSMS will provide opportunities to gain experience from pharmacists, surgeons and medical oncologists who help deliver the course. You’ll work with our staff whose expertise and reputation in translational cancer research is supported by Cancer Research UK, the Rosetrees Trust and the Boltini Trust.
This programme is available for intercalated study if you are a medical student looking to specialise in this increasingly popular field of medicine.
This MSc gives pharmacy, biochemistry, biomedical and biology graduates the opportunity to help shape the future of healthcare, through the study of precision medicine and oncology.
Precision medicine personalises disease prevention and treatment, considering the differences in people’s genes, environments, and lifestyles to target the right treatments, to the right patients, at the right time.
Alongside this, you’ll determine advances in omics strategies, to identify and profile cancer tumours, including DNA profiling and sequencing, mRNA patterns, protein and phosphorylated protein expression, and lipid alternations in oncology. You’ll learn approaches to identify novel therapeutic targets and predictive biomarkers to recognise patients that are likely to benefit from specific treatment.
This highly specialised course has a large clinical component and includes an optional placement at Brighton and Sussex University Hospital, or in Brighton and Sussex Medical School (BSMS) or campus-based omics labs.
Our established links with NHS trusts and BSMS will provide opportunities to gain experience from pharmacists, surgeons and medical oncologists who help deliver the course. You’ll work with our staff whose expertise and reputation in translational cancer research is supported by Cancer Research UK, the Rosetrees Trust and the Boltini Trust.
This programme is available for intercalated study if you are a medical student looking to specialise in this increasingly popular field of medicine.
